In this study, a pyrimidinethione candidate carrying pyrazole and thiophene scaffolds was produced using Biginelli cyclo-condensation reaction of pyrazole aldehyde with pentan-2,4-dione and thiourea. To create some heteroannulated compounds, thiazolopyrimidines, the former underwent cyclocondensation reactions with ethyl chloroacetate, 1,2-dibromoethane, chloroacetonitrile, and oxalyl chloride. For the purpose of determining the molecular geometry and frontier orbital analysis, DFT simulation was run. Compound 8 displayed the highest softness and lowest energy gap among DFT calculations. Besides, it has the highest electrophilicity index, demonstrating biological impacts. The compounds obtained were evaluated against cell lines of breast adenocarcinoma (MCF7) and hepatocellular carcinoma (HepG2) as antiproliferative agents. A molecular docking simulation was performed towards EGFR enzyme to demonstrate the rationality of our design and discover their binding modes. The modeling pharmacokinetics analysis showed their anticipated and desirable drug-likeness and bioavailability properties.